Phase 4
Completed N=97
Steroids After Laser Trabeculoplasty for Glaucoma
Source: ClinicalTrials.gov NCT00981435 ↗Enrolled (actual)
97
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcomePrimary: Intraocular Pressure (IOP) Change — -3.0; -6.2; -5.2 mmHg
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intraocular Pressure (IOP) Change |
-3.0; -6.2; -5.2 | — |
| SECONDARY Intraocular Inflammation |
0; 0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- clinical diagnosis of glaucoma
- clinician has determined that SLT laser is indicated
- IOP currently >18 and was ever >21 in the past (e.g. prior to treatment)
Exclusion Criteria
- prior history of uveitis
- prior glaucoma surgery including glaucoma laser surgery
- pregnant or 3 months post-partum
Data sourced from ClinicalTrials.gov (NCT00981435). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.